BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31004935)

  • 21. Peripheral blood mononuclear cell-converted induced pluripotent stem cells (iPSCs) from an early onset Alzheimer's patient.
    Lee HK; Morin P; Xia W
    Stem Cell Res; 2016 Mar; 16(2):213-5. PubMed ID: 27345971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of an integration-free iPSC line(SYSUi001-A) from a sporadic Alzheimer's disease patient.
    Wei R; Han H; Ye M; He L; Lei Q; Zhou T; Cai X; Li Z
    Stem Cell Res; 2019 Mar; 35():101375. PubMed ID: 30797990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human fibroblast and stem cell resource from the Dominantly Inherited Alzheimer Network.
    Karch CM; Hernández D; Wang JC; Marsh J; Hewitt AW; Hsu S; Norton J; Levitch D; Donahue T; Sigurdson W; Ghetti B; Farlow M; Chhatwal J; Berman S; Cruchaga C; Morris JC; Bateman RJ; ; Pébay A; Goate AM
    Alzheimers Res Ther; 2018 Jul; 10(1):69. PubMed ID: 30045758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Derivation of induced pluripotent stem cells from a familial Alzheimer's disease patient carrying the L282F mutation in presenilin 1.
    Poon A; Li T; Pires C; Nielsen TT; Nielsen JE; Holst B; Dinnyes A; Hyttel P; Freude KK
    Stem Cell Res; 2016 Nov; 17(3):470-473. PubMed ID: 27789396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disease-specific induced pluripotent stem cells: a platform for human disease modeling and drug discovery.
    Jang J; Yoo JE; Lee JA; Lee DR; Kim JY; Huh YJ; Kim DS; Park CY; Hwang DY; Kim HS; Kang HC; Kim DW
    Exp Mol Med; 2012 Mar; 44(3):202-13. PubMed ID: 22179105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
    Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
    Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation of induced pluripotent stem cells (iPSCs) from a retinoblastoma patient carrying a c.2663G>A mutation in RB1 gene.
    Zeng S; Liu L; Ouyang Q; Zhao Y; Lin G; Hu L; Li W
    Stem Cell Res; 2016 Sep; 17(2):208-211. PubMed ID: 27879208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of induced pluripotent stem cell lines IRMBi003-A and IRMBi003-B from a healthy donor to model Alzheimer's disease.
    Clua Provost C; Auboyer L; Rovelet-Lecrux A; Monzo C; Schob E; Andreux F; Quittet C; Lehmann S; Wallon D; Crozet C
    Stem Cell Res; 2023 Dec; 73():103250. PubMed ID: 37979430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation of an induced pluripotent stem cell (iPSC) line, DHMCi005-A, from a patient with CALFAN syndrome due to mutations in SCYL1.
    Lenz D; Staufner C; Wächter S; Hagedorn M; Ebersold J; Göhring G; Kölker S; Hoffmann GF; Jung-Klawitter S
    Stem Cell Res; 2019 May; 37():101428. PubMed ID: 30959346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Establishment of a human iPSC line (MUSIi007-A) from peripheral blood of normal individual using Sendai viral vectors.
    Potirat P; Wattanapanitch M; Kheolamai P; Issaragrisil S
    Stem Cell Res; 2018 Oct; 32():43-46. PubMed ID: 30172906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induced pluripotent stem cell (iPSC) line from an epidermolysis bullosa simplex patient heterozygous for keratin 5 E475G mutation and with the Dowling Meara phenotype.
    Kolundzic N; Khurana P; Hobbs C; Rogar M; Ropret S; Törmä H; Ilic D; Liovic M
    Stem Cell Res; 2019 May; 37():101424. PubMed ID: 30933721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reprogramming Methods Do Not Affect Gene Expression Profile of Human Induced Pluripotent Stem Cells.
    Trevisan M; Desole G; Costanzi G; Lavezzo E; Palù G; Barzon L
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Establishment of TUSMi008-A, an induced pluripotent stem cell (iPSC) line from a 76-year old Alzheimer's disease (AD) patient with PAXIP1 gene mutation.
    Wang Y; Zhang J; Hu J; Li G; Lei Y; Zhao J
    Stem Cell Res; 2019 Apr; 36():101391. PubMed ID: 30831521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human induced pluripotent stem cell line from fibroblasts (HEBHMUi015-A) and chondrogenic differentiation.
    Zhang Y; Liu Y; Yan W; Zhang X; Hou Y; Zhou Z; Guo R; Liu G; Ma J
    Stem Cell Res; 2023 Oct; 72():103201. PubMed ID: 37856927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of two iPSC lines with either a heterozygous V717I or a heterozygous KM670/671NL mutation in the APP gene.
    Frederiksen HR; Holst B; Ramakrishna S; Muddashetty R; Schmid B; Freude K
    Stem Cell Res; 2019 Jan; 34():101368. PubMed ID: 30634129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation of a human induced pluripotent stem cell (iPSC) line from a 64year old male patient with multiple schwannoma.
    Zhang S; Lv Z; Hu Y; Liu L; Gong W; Li Q; Wu H
    Stem Cell Res; 2017 Mar; 19():49-51. PubMed ID: 28413006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation of the human induced pluripotent stem cell line UKWNLi002-A from dermal fibroblasts of a woman with a heterozygous c.608 C>T (p.Thr203Met) mutation in exon 3 of the nerve growth factor gene potentially associated with hereditary sensory and autonomic neuropathy type 5.
    Klein T; Henkel L; Klug K; Kwok CK; Klopocki E; Üçeyler N
    Stem Cell Res; 2018 Dec; 33():171-174. PubMed ID: 30384131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation of an induced pluripotent stem cell (iPSC) line from a patient with autosomal dominant retinitis pigmentosa due to a mutation in the NR2E3 gene.
    Terray A; Slembrouck A; Nanteau C; Chondroyer C; Zeitz C; Sahel JA; Audo I; Reichman S; Goureau O
    Stem Cell Res; 2017 Oct; 24():1-4. PubMed ID: 29034877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymphoblastoids cell lines - Derived iPSC line from a 26-year-old myotonic dystrophy type 1 patient carrying (CTG)
    Martineau L; Racine V; Benichou SA; Puymirat J
    Stem Cell Res; 2018 Jan; 26():103-106. PubMed ID: 29274549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of integration-free human induced pluripotent stem cells from a patient with sporadic Parkinson's disease.
    Lee Y; Jeong D; Ham S; Son J; Ko K
    Stem Cell Res; 2024 Jun; 77():103416. PubMed ID: 38615589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.